Crinetics Pharmaceuticals, Inc. Annual Return On Assets in % from 2019 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Crinetics Pharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from 2019 to 2023.
  • Crinetics Pharmaceuticals, Inc. Return On Assets for the quarter ending June 30, 2024 was -32.4 %, a 40.8% increase year-over-year.
  • Crinetics Pharmaceuticals, Inc. annual Return On Assets for 2023 was -45.5 %, a 3.64% decline from 2022.
  • Crinetics Pharmaceuticals, Inc. annual Return On Assets for 2022 was -43.9 %, a 3.98% increase from 2021.
  • Crinetics Pharmaceuticals, Inc. annual Return On Assets for 2021 was -45.8 %, a 12.3% decline from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -45.5 -1.6 -3.64% Jan 1, 2023 Dec 31, 2023
2022 -43.9 +1.82 +3.98% Jan 1, 2022 Dec 31, 2022
2021 -45.8 -5.03 -12.3% Jan 1, 2021 Dec 31, 2021
2020 -40.7 -6.83 -20.1% Jan 1, 2020 Dec 31, 2020
2019 -33.9 Jan 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.